A Conversation About the PHA Registry
Recorded on August 18, 2021
Dan Grinnan, M.D., speaks with one of his pulmonary hypertension (PH) patients, Shirl Rhodes, about her enrollment in the PHA Registry (PHAR), a registry of patients with pulmonary arterial hypertension (PAH), pediatric PH due to developmental lung disease and chronic thromboembolic pulmonary hypertension (CTEPH). Learn what it is like to participate in the PHAR and how PHAR supports PH research.
About the Speakers
Dan Grinnan, M.D.
Dan Grinnan, M.D., is director of Virginia Commonwealth University Health’s Comprehensive Care Center for Pulmonary Hypertension. He has served as chair of the PHAR Steering Committee and is a member of the PHCC Accreditation Committee.
Shirl Rhodes is a PH patient participating in the PHAR through the Virginia Commonwealth University PHCC. She is a former compliance and safety manager and lives in rural Virginia.
PHA thanks Bayer for its Platinum Sponsorship and Janssen Pharmaceuticals, Inc. for its Diamond Sponsorship of the PHA Connects fund, which provides support to this PHA Live event.